Baxter (BAX) International debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American Organization for Nursing Leadership Conference. The IV Verify system is designed to streamline nursing workflows, save clinician time and support safer medication administration at the bedside. Baxter’s launch of the product is the result of a strategic and exclusive distribution agreement with Vigilant Software, a leader in medication management safe practices.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX:
- Baxter Names Interim CFO as Board Refresh Continues
- Balanced Risk Profile and Execution Uncertainty Justify Hold Rating on Baxter Post S&P Outlook Downgrade
- Baxter International Appoints Interim CFO Amid Leadership Transition
- Baxter CFO Joel Grade to depart
- Baxter backs FY26 adjusted EPS view $1.85-$2.05, consensus $1.92